Helminthiasis
MONDO:0004664A parasitic infection characterized by the infestation with worms, mainly in the intestine.
Also known as: helminthiasis, worm infection
65 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
One pill to wipe out worms? new trial tests Game-Changing treatment
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether a single dose of a new drug, emodepside, can cure infections from soil-transmitted worms (like whipworm, hookworm, and roundworm) better than the current standard treatment, mebendazole, which requires multiple doses. About 315 adolescents and adults with…
Phase: PHASE3 • Sponsor: Swiss Tropical & Public Health Institute • Aim: ⭐️ CURE ⭐️
Last updated Aug 16, 2026 00:00 UTC
-
New whipworm drug could beat standard treatment in one dose
Disease control Not yet recruitingThis study compares a single dose of emodepside to a single dose of albendazole (the usual treatment) in 100 adolescents and adults infected with a type of whipworm. The goal is to see which drug cures more infections and reduces egg counts. Participants provide stool samples bef…
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can extra doses of an old drug reverse liver scarring?
Disease control Not yet recruitingThis trial tests whether giving praziquantel three times a year, instead of the standard once a year, can improve liver fibrosis (scarring) caused by schistosomiasis in people aged 15-40 in Uganda. Participants with liver fibrosis will be randomly assigned to one of two treatment…
Phase: PHASE2, PHASE3 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a Two-Drug combo beat whipworm in kids?
Disease control Not yet recruitingThis phase 3 trial tests whether combining two drugs—albendazole and ivermectin—works better than the standard single drug for treating whipworm infection in schoolchildren aged 6 to 15 in Honduras. Participants receive a single dose of either placebo, albendazole alone, albendaz…
Phase: PHASE3 • Sponsor: Mundo Sano Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could one dose beat two? new trial tests simpler treatment for parasitic liver disease
Disease control Not yet recruitingThis study tests whether one or two doses of the drug oxfendazole can cure chronic fascioliasis (a liver infection caused by a parasite) as well as the standard two-dose treatment with triclabendazole. About 336 adults in Peru will be randomly assigned to one of three groups. Res…
Phase: PHASE2 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a single dose beat brain worms? new trial aims to find out
Disease control Not yet recruitingThis study tests a drug called oxfendazole for people with mild brain cysticercosis, a parasitic infection that can cause seizures. Researchers will compare a single dose and three doses of oxfendazole against the standard combination therapy. The goal is to see if oxfendazole cl…
Phase: PHASE2, PHASE3 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Surgeons to operate robot from 1,500 miles away to remove liver parasites
Disease control Not yet recruitingThis early-stage trial will test whether surgeons in Chengdu can safely remove liver parasites from 10 patients in Lhasa (3,650m altitude) using a 5G-connected robot. The goal is to see if the remote surgery can be completed without major issues. If it works, it could bring exper…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study eyes selexipag for neglected form of lung hypertension
Disease control Not yet recruitingThis study looks at how well the oral medication selexipag works over the long term for people with a specific type of lung hypertension caused by schistosomiasis (a parasitic infection). Researchers will compare patients who received selexipag as part of routine care to similar …
Sponsor: Caio Júlio César dos Santos Fernandes • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a new drug combo wipe out three parasitic diseases at once?
Disease control Not yet recruitingThis large study in Fiji tests whether a new combination of drugs (moxidectin plus two others) can safely treat three common parasitic infections: lymphatic filariasis, scabies, and strongyloidiasis. About 5,100 people will receive either the new combo or the standard treatment o…
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 26, 2026 14:32 UTC
-
AI app aims to help frontline workers diagnose neglected skin diseases
Diagnosis Not yet recruitingThis study tests whether a mobile app using artificial intelligence can help frontline health workers in sub-Saharan Africa better diagnose skin-related neglected tropical diseases, like leprosy and scabies. Researchers will collect images from dermatologists to train the AI, the…
Phase: NA • Sponsor: Kenya Medical Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Simple urine test could revolutionize schistosomiasis detection
Diagnosis Not yet recruitingThis study aims to develop a new urine test for schistosomiasis, a parasitic infection. Researchers will test a nanobody-based strip on 2500 participants, comparing it to the standard microscope method. If accurate, it could offer a quick, non-invasive diagnostic tool.
Sponsor: Pemba Ministry of Health Zanzibar • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Heart-Lung connection may explain survival advantage in Parasite-Linked hypertension
Knowledge-focused Not yet recruitingThis study looks at how well the right side of the heart works with the lungs in people who have high blood pressure in their lung arteries caused by schistosomiasis, a parasitic infection common in parts of Africa and South America. Researchers will use echocardiography to measu…
Phase: NA • Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Egyptian schistosomiasis study launches to map disease hotspots
Knowledge-focused Not yet recruitingThis study will measure how many people in Assiut Governorate, Egypt, have schistosomiasis, a parasitic disease. Researchers will test urine and stool samples from 359 participants and ask about risk factors. The goal is to better understand the current burden of the disease in t…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
House M.D. episode tested as health education tool for rare brain infection
Knowledge-focused Not yet recruitingThis study tests whether watching a single episode of the medical drama House M.D. can boost knowledge about neurocysticercosis, a parasitic brain infection that can cause epilepsy. Sixty young adults aged 18-35 will be randomly assigned to either watch the episode or not, and th…
Phase: NA • Sponsor: Cephas Health Research Initiative Inc, Ibadan, Nigeria • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to bring mental health support to people with neglected skin diseases in ghana
Knowledge-focused Not yet recruitingThis study will test a new way to care for people in Ghana who have both a neglected tropical skin disease (like leprosy or Buruli ulcer) and mental health challenges like depression or anxiety. Researchers will work with 200 affected adults and local health workers to create a G…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC